Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 230Squamous Cell Carcinoma of Head and Neck 139Head and Neck Neoplasms 131Lung Neoplasms 117Esophageal Neoplasms 88Stomach Neoplasms 84Uterine Cervical Neoplasms 68Esophageal Squamous Cell Carcinoma 66Urinary Bladder Neoplasms 59Breast Neoplasms 55Nasopharyngeal Carcinoma 51Small Cell Lung Carcinoma 46Carcinoma, Squamous Cell 39Neoplasm Metastasis 38Pancreatic Neoplasms 36Neoplasms 35Biliary Tract Neoplasms 34Oropharyngeal Neoplasms 32Cholangiocarcinoma 32Ovarian Neoplasms 30Mesothelioma, Malignant 28Adenocarcinoma Of Esophagus 28Lymphoma 25Carcinoma 24Adenocarcinoma of Lung 24Central Nervous System Neoplasms 22Laryngeal Neoplasms 20Carcinoma, Ovarian Epithelial 20Recurrence 19Lymphoma, Large B-Cell, Diffuse 19

Interventions

atezolizumab 2Sorafenib 2Bevacizumab 2titanium silicide 1ledipasvir, sofosbuvir drug combination 1halofantrine 1genexol-PM 1durvalumab 1avatrombopag 1aumolertinib 1Sunitinib 1Ramucirumab 1Neoadjuvant Therapy 1N-monoacetylcystine 1Leucovorin 1Injections 1Immunotherapy 1Formyltetrahydrofolates 1Everolimus 1Cisplatin 1Catheter Ablation 1Adjuvants, Pharmaceutic 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Liver Diseases × Cisplatin × Clear all
NCT03519074 2024-09-19

Cisplatin Combined with Oral TS-1 in Patients with Advanced Solid Tumors with Different Degrees of Liver Dysfunction

National University Hospital, Singapore

Phase 2 Active not recruiting
48 enrolled

Liver Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡